Cargando…
Effectiveness of eradication therapy for Helicobacter pylori infection in Africa: a systematic review and meta-analysis
BACKGROUND: The effectiveness of Helicobacter pylori (H. pylori) eradication depends on the treatment protocol. This study investigates the H. pylori eradication rate in Africa using the best available evidence from databases. METHODS: Databases were searched and results were pooled together. Hetero...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990047/ https://www.ncbi.nlm.nih.gov/pubmed/36882697 http://dx.doi.org/10.1186/s12876-023-02707-5 |
_version_ | 1784901868210618368 |
---|---|
author | Fekadu, Sintayehu Engiso, Hizkel Seyfe, Sisay Iizasa, Hisashi Godebo, Ashebir Deyno, Serawit Yoshiyama, Hironori |
author_facet | Fekadu, Sintayehu Engiso, Hizkel Seyfe, Sisay Iizasa, Hisashi Godebo, Ashebir Deyno, Serawit Yoshiyama, Hironori |
author_sort | Fekadu, Sintayehu |
collection | PubMed |
description | BACKGROUND: The effectiveness of Helicobacter pylori (H. pylori) eradication depends on the treatment protocol. This study investigates the H. pylori eradication rate in Africa using the best available evidence from databases. METHODS: Databases were searched and results were pooled together. Heterogeneity between studies was assessed using I(2) test statistics. Stata version 13 software was employed to compute the pooled eradication rate. In the subgroup analysis comparison, the finding is considered significant when the confidence intervals did not overlap. RESULTS: Twenty-two studies from 9 African countries with a total population of 2,163 were included in this study. The pooled eradication rate of H. pylori was 79% (95% CI: 75%-82%), heterogeneity (I(2) = 93.02%). In the subgroup analysis by study design, a higher eradication rate was reported from observational studies (85%, 95% CI: 79%-90%), compared to randomized control trials (77%, 95% CI: 73%-82%); by the duration of therapy, higher eradication rate was reported in 10-days regimen (88%, 95% CI: 84%-92%), compared to 7-days regimen (66%, 95% CI: 55%-77%); by country, the highest eradication rate was found in Ethiopia (90%; 95% CI: 87%-93%) and the lowest eradication rate was reported in Ivory Coast (22.3%; 95% CI:15%-29%); by type of H. pylori test, the highest eradication rate was reported when rapid urease test coupled with histology (88%, 95% CI: 77%-96%), and the lowest eradication rate was reported with histology alone (22.3%; 95% CI:15%-29%). Significant heterogeneity was observed with pooled prevalence (I(2) = 93.02%, P < 0.000). CONCLUSIONS: In Africa, the first-line therapy showed a variable eradication rate for H. pylori. This study demonstrates the necessity to optimize current H. pylori treatment regimens in each country, taking into account the antibiotic susceptibility. Future RCT studies with standardized regimens are warranted. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-023-02707-5. |
format | Online Article Text |
id | pubmed-9990047 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-99900472023-03-07 Effectiveness of eradication therapy for Helicobacter pylori infection in Africa: a systematic review and meta-analysis Fekadu, Sintayehu Engiso, Hizkel Seyfe, Sisay Iizasa, Hisashi Godebo, Ashebir Deyno, Serawit Yoshiyama, Hironori BMC Gastroenterol Research BACKGROUND: The effectiveness of Helicobacter pylori (H. pylori) eradication depends on the treatment protocol. This study investigates the H. pylori eradication rate in Africa using the best available evidence from databases. METHODS: Databases were searched and results were pooled together. Heterogeneity between studies was assessed using I(2) test statistics. Stata version 13 software was employed to compute the pooled eradication rate. In the subgroup analysis comparison, the finding is considered significant when the confidence intervals did not overlap. RESULTS: Twenty-two studies from 9 African countries with a total population of 2,163 were included in this study. The pooled eradication rate of H. pylori was 79% (95% CI: 75%-82%), heterogeneity (I(2) = 93.02%). In the subgroup analysis by study design, a higher eradication rate was reported from observational studies (85%, 95% CI: 79%-90%), compared to randomized control trials (77%, 95% CI: 73%-82%); by the duration of therapy, higher eradication rate was reported in 10-days regimen (88%, 95% CI: 84%-92%), compared to 7-days regimen (66%, 95% CI: 55%-77%); by country, the highest eradication rate was found in Ethiopia (90%; 95% CI: 87%-93%) and the lowest eradication rate was reported in Ivory Coast (22.3%; 95% CI:15%-29%); by type of H. pylori test, the highest eradication rate was reported when rapid urease test coupled with histology (88%, 95% CI: 77%-96%), and the lowest eradication rate was reported with histology alone (22.3%; 95% CI:15%-29%). Significant heterogeneity was observed with pooled prevalence (I(2) = 93.02%, P < 0.000). CONCLUSIONS: In Africa, the first-line therapy showed a variable eradication rate for H. pylori. This study demonstrates the necessity to optimize current H. pylori treatment regimens in each country, taking into account the antibiotic susceptibility. Future RCT studies with standardized regimens are warranted. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-023-02707-5. BioMed Central 2023-03-07 /pmc/articles/PMC9990047/ /pubmed/36882697 http://dx.doi.org/10.1186/s12876-023-02707-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Fekadu, Sintayehu Engiso, Hizkel Seyfe, Sisay Iizasa, Hisashi Godebo, Ashebir Deyno, Serawit Yoshiyama, Hironori Effectiveness of eradication therapy for Helicobacter pylori infection in Africa: a systematic review and meta-analysis |
title | Effectiveness of eradication therapy for Helicobacter pylori infection in Africa: a systematic review and meta-analysis |
title_full | Effectiveness of eradication therapy for Helicobacter pylori infection in Africa: a systematic review and meta-analysis |
title_fullStr | Effectiveness of eradication therapy for Helicobacter pylori infection in Africa: a systematic review and meta-analysis |
title_full_unstemmed | Effectiveness of eradication therapy for Helicobacter pylori infection in Africa: a systematic review and meta-analysis |
title_short | Effectiveness of eradication therapy for Helicobacter pylori infection in Africa: a systematic review and meta-analysis |
title_sort | effectiveness of eradication therapy for helicobacter pylori infection in africa: a systematic review and meta-analysis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990047/ https://www.ncbi.nlm.nih.gov/pubmed/36882697 http://dx.doi.org/10.1186/s12876-023-02707-5 |
work_keys_str_mv | AT fekadusintayehu effectivenessoferadicationtherapyforhelicobacterpyloriinfectioninafricaasystematicreviewandmetaanalysis AT engisohizkel effectivenessoferadicationtherapyforhelicobacterpyloriinfectioninafricaasystematicreviewandmetaanalysis AT seyfesisay effectivenessoferadicationtherapyforhelicobacterpyloriinfectioninafricaasystematicreviewandmetaanalysis AT iizasahisashi effectivenessoferadicationtherapyforhelicobacterpyloriinfectioninafricaasystematicreviewandmetaanalysis AT godeboashebir effectivenessoferadicationtherapyforhelicobacterpyloriinfectioninafricaasystematicreviewandmetaanalysis AT deynoserawit effectivenessoferadicationtherapyforhelicobacterpyloriinfectioninafricaasystematicreviewandmetaanalysis AT yoshiyamahironori effectivenessoferadicationtherapyforhelicobacterpyloriinfectioninafricaasystematicreviewandmetaanalysis |